Notice of Full Year Results | 08-Apr-2024 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 19-Mar-2024 | 14:47 | RNS |
Clinical development update | 31-Jan-2024 | 07:00 | RNS |
Appointment of Nominated Adviser and Sole Broker | 22-Jan-2024 | 07:00 | RNS |
Year End Business Update | 04-Jan-2024 | 07:00 | RNS |
Grant of Share Options | 20-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 19-Oct-2023 | 07:00 | RNS |
XF Pipeline Update Meeting | 17-Oct-2023 | 07:01 | RNS |
Publication of new microbiological data for XF-73 | 17-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 10-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 04-Oct-2023 | 12:34 | RNS |
Notice of XF Pipeline Update Meeting | 27-Sep-2023 | 07:00 | RNS |
Interim Results | 20-Sep-2023 | 07:00 | RNS |
Notice of Interim Results | 23-Aug-2023 | 07:00 | RNS |
Publication of new data for XF-73 | 31-Jul-2023 | 12:01 | RNS |
Currency | UK Pounds |
Share Price | 21.50p |
Change Today | -0.50p |
% Change | -2.27 % |
52 Week High | 82.00 |
52 Week Low | 17.50 |
Volume | 184,683 |
Shares Issued | 95.31m |
Market Cap | £20.49m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:29 | 2,000 @ 21.08p |
16:29 | 5,000 @ 21.10p |
16:24 | 2,102 @ 21.50p |
16:24 | 113 @ 22.00p |
16:24 | 1,398 @ 21.50p |
You are here: research